Dave Sekera

In a fascinating discussion, Dave Sekera, the Chief U.S. markets strategist at Morningstar, shares his insights on current market volatility driven by earnings and geopolitical factors. He unpacks the implications of tariffs on various industries while focusing on analyzing inflation trends through upcoming economic reports. Sekera also evaluates recent earnings from Gilead and Kraft Heinz, dives into stock performance for tech giants like Alphabet and Amazon, and highlights strong growth potential in the AI sector.

This week features Dave Sekera, Morningstar's chief U.S. market strategist, who dives into the latest economic trends. He discusses the outlook for inflation and major bank earnings, emphasizing the importance of retail sales. With potential impacts from political shifts, he highlights investment strategies for 2026, recommending a balanced approach between AI stocks and high-quality value assets. Plus, Sekera shares five stock picks, including strong cases for companies like SLB and Mondelez, perfect for savvy investors.

Dave Sekera, Morningstar's Chief U.S. markets strategist, dives into economic trends and stock analysis. He discusses the significance of GDP and inflation changes, offering a cautionary outlook on the market. The conversation shifts to NVIDIA, analyzing expectations ahead of its earnings report and its performance in AI workloads. Sekera also evaluates Walmart, Gilead Sciences, and Hasbro's recent financial results, revealing investment potentials amidst evolving consumer habits and market dynamics.

Dave Sekera, Morningstar’s Chief U.S. Market Strategist, offers market analysis and stock calls. He discusses how Iran war news and Fed rate direction could move markets. He examines inflation report risks, why Anthropic’s Mythos impacts cybersecurity demand, and whether Nike, Carnival, McCormick, and several small-cap names face trouble. He closes with stocks he thinks are vulnerable if inflation heats up.

Join Dave Sekera, Chief U.S. Markets Strategist at Morningstar, as he shares insights on the current stock landscape. He dissects economic indicators, including key payroll data, and the performance of AI stocks like NVIDIA. Dave also discusses stocks to sell—like Eli Lilly and Wingstop due to valuation concerns—and highlights promising picks such as W.K. Kellogg. With a focus on value stocks and high dividend yields, his expert analysis equips listeners with actionable investment strategies amidst a complex market.

Dave Sekera, Chief US Market Strategist at Morningstar Research Services, shares his insights into the economic outlook for 2025. He discusses the overvaluation of growth stocks, emphasizing the appeal of value stocks. Sekera highlights the undervalued healthcare sector and potential opportunities arising from falling inflation and interest rates. Additionally, he touches on the importance of strong economic moats for competitive advantage and the need for a strategic shift in investment approaches in the evolving market landscape.

Dave Sekera, Morningstar's Chief U.S. Market Strategist, shares insightful stock analysis and investment philosophy. He reflects on the importance of reviewing past stock picks and the lessons learned from wins and losses. Dave discusses several companies, including Baxter's challenges, Alphabet’s strong fundamentals due to AI innovations, and AMD’s strategic partnerships. He wraps up by highlighting four undervalued stocks for 2026: Biogen, Microsoft, LPL Financial, and Devon Energy, showcasing their potential for future gains.

Dave Sekera, Morningstar Chief U.S. Market Strategist who provides market outlooks and stock analysis. He discusses whether Chewy’s surge is a buy, valuations and sector shifts heading into Q2, which sectors to harvest and where to redeploy proceeds. He also outlines Morningstar’s five undervalued stock picks for the start of the quarter.

Dave Sekera, Morningstar’s chief U.S. market strategist who provides market commentary and stock analysis. He discusses which earnings and economic reports to watch, whether Nvidia and Salesforce remain attractive, the AMD–Meta partnership, private credit risks revealed by Blue Owl, and five value stocks that still look appealing.

In this discussion, Dave Sekera, Morningstar's Chief U.S. markets strategist, dives into the impact of tariff uncertainty on the stock market. He highlights intriguing stock picks like Dollar General and Adobe amidst economic fluctuations. Sekera emphasizes the shift toward value stocks, spotlighting healthcare and energy sectors as ripe for investment. He also identifies Clorox as an undervalued gem in consumer defense, showcasing its strong brand and dividend yield. Tune in for insights on navigating the evolving market landscape!